In an inverse relationship, PDCD4 expression was found to be increased with diminished ovarian cancer differentiation (11), while treatment of human smooth muscle cells with bone morphogenetic protein 4 (BMP-4) and transforming growth factor beta (TGF-β) was found to decrease PDCD4 expression during smooth muscle differentiation (41). This evidence concerns the gene PDCD4 and ovarian carcinoma.